All entries for: ODDIFACT SAS

October 16, 2025

ODDIFACT SAS

Orphan Drug Designation

FDA orphan drug designation: treatment of bullous pemphigoid

Disease Area: Rare Diseases
July 18, 2025

ODDIFACT SAS

Orphan Drug Designation

FDA orphan drug designation: treatment of autoimmune hemolytic anemia

Disease Area: Rare Diseases
Scroll to Top